Skip to content ↓

CBI hosting Oct. 23 roundtable on drug safety

Press Contact:

Teresa Herbert
Phone: 617-258-5403
MIT News Office
Close

The Center for Biomedical Innovation at MIT will host a roundtable discussion, "Improving Drug Safety: Critical Elements of a 'Learning Healthcare System,'" at 2 p.m. Oct. 23 at the Royal Sonesta Hotel in Cambridge. The event is free and open to the public.

Presented in collaboration with MIT's Engineering Systems Division and the New England Healthcare Institute, participants in the discussion include Dr. Mark McClellan, director of the Engelberg Center for Health Care Reform at the Brookings Institution, Dr. Glen Forbes, CEO of the Mayo Clinic's Rochester Campus, as well as MIT faculty members Richard Larson, Nancy Leveson and Debbie Nightingale.

The discussion will be moderated by Dr. Garry Neil, corporate vice president, Corporate Office of Science and Technology at Johnson & Johnson. To RSVP e-mail mfrankel@mit.edu or call 617-253-0902.

A version of this article appeared in MIT Tech Talk on October 22, 2008 (download PDF).

Related Links

Related Topics

More MIT News

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story